Atopic Dermatitis Drugs Market Size, Share & Trends Report

Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Biologics, PDE4 Inhibitors), By Route Of Administration (Topical, Injectable, Oral), By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-2-68038-546-5
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry: Healthcare

Market Segmentation

Atopic Dermatitis Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Corticosteroids
- Calcineurin Inhibitors
- PDE4 Inhibitors
- Biologics
- Others
Atopic Dermatitis Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Topical
- Injectable
- Oral
Atopic Dermatitis Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Atopic Dermatitis Drugs Market, By Drug Class
    - Corticosteroids
    - Calcineurin Inhibitors
    - PDE4 Inhibitors
    - Biologics
    - Others
  - North America Atopic Dermatitis Drugs Market, By Route of Administration
    - Topical
    - Injectable
    - Oral
  - U.S.
    - U.S Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - U.S Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Canada
    - Canada Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Canada Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
- Europe
  - Europe Atopic Dermatitis Drugs Market, By Drug Class
    - Corticosteroids
    - Calcineurin Inhibitors
    - PDE4 Inhibitors
    - Biologics
    - Others
  - Europe Atopic Dermatitis Drugs Market, By Route of Administration
    - Topical
    - Injectable
    - Oral
  - U.K.
    - U.K. Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - U.K. Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - France
    - France Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - France Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Germany
    - Germany Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Germany Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Italy
    - Italy Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Italy Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Spain
    - Spain Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Spain Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
- Asia Pacific
  - Asia Pacific Atopic Dermatitis Drugs Market, By Drug Class
    - Corticosteroids
    - Calcineurin Inhibitors
    - PDE4 Inhibitors
    - Biologics
    - Others
  - Asia Pacific Atopic Dermatitis Drugs Market, By Route of Administration
    - Topical
    - Injectable
    - Oral
  - Japan
    - Japan Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Japan Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - China
    - China Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - China Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - India
    - India Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - India Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - South Korea
    - South Korea Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - South Korea Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Australia
    - Australia Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Australia Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
- Latin America
  - Latin America Atopic Dermatitis Drugs Market, By Drug Class
    - Corticosteroids
    - Calcineurin Inhibitors
    - PDE4 Inhibitors
    - Biologics
    - Others
  - Latin America Atopic Dermatitis Drugs Market, By Route of Administration
    - Topical
    - Injectable
    - Oral
  - Brazil
    - Brazil Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Brazil Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Argentina
    - Argentina Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Argentina Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Mexico
    - Mexico Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Mexico Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
- Middle East and Africa
  - Middle East and Africa Atopic Dermatitis Drugs Market, By Drug Class
    - Corticosteroids
    - Calcineurin Inhibitors
    - PDE4 Inhibitors
    - Biologics
    - Others
  - Middle East and Africa Atopic Dermatitis Drugs Market, By Route of Administration
    - Topical
    - Injectable
    - Oral
  - South Africa
    - South Africa Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - South Africa Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - Saudi Arabia
    - Saudi Arabia Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - Saudi Arabia Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral
  - UAE
    - UAE Atopic Dermatitis Drugs Market, By Drug Class
      - Corticosteroids
      - Calcineurin Inhibitors
      - PDE4 Inhibitors
      - Biologics
      - Others
    - UAE Atopic Dermatitis Drugs Market, By Route of Administration
      - Topical
      - Injectable
      - Oral

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.